Novel drug regimen can improve stem cell transplantation outcomes – Medical Xpress
|
Novel drug regimen can improve stem cell transplantation outcomes
Medical Xpress Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber … Stem Cell Transplants can be improved by New Drug RegimenTopNews United States |
